Chemogenics biopharma, LLC:1210198 [19-003278]

Ended Purchase Order Awarded

Contract number
75N95019P00462
Awardee
Awarding agency
Obligated
$24,900

Award facts

Contract value 100% obligated
$24,900.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a $24,900.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a for-profit limited liability company and sole proprietorship, on July 23, 2019. The contract has a completion date of September 30, 2019 and does not have a set-aside designation. Chemogenics Biopharma, LLC is a leading company in preclinical drug discovery and has been awarded several contracts by the NIH to provide services related to drug development and analysis, including a $249,500 contract in 2022 for synthesis and bioanalytical analysis support services.

Quick answers

Who was awarded contract 75N95019P00462?

75N95019P00462 was awarded to Chemogenics Biopharma, LLC by National Institute on Drug Abuse (National Institutes of Health) on July 23, 2019.

How much is contract 75N95019P00462 worth?

The government has obligated $24,900 on 75N95019P00462.

Was contract 75N95019P00462 competed?

The extent of competition for 75N95019P00462 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login